H. Desmurs-Clavel

发表

Highly sensitive serum cardiac troponin T and cardiovascular events in patients with systemic lupus erythematosus (TROPOPLUS study).

Z. Amoura, N. Costedoat-Chalumeau, N. Morel, 2020, Rheumatology.

Hydroxychloroquine levels in patients with systemic lupus erythematosus: whole blood is preferable but serum levels also detect non-adherence

É. Oksenhendler, J. Piette, A. Dupuy, 2020, Arthritis Research & Therapy.

The modification of the thrombin generation assay for the clinical assessment of hypercoagulability in patients receiving heparin therapy

M. Simon, Y. Dargaud, H. Desmurs-Clavel, 2021, International journal of laboratory hematology.

Anti-Domain I β2-Glycoprotein I Antibodies and Activated Protein C Resistance Predict Thrombosis in Antiphospholipid Syndrome: TAC(I)T Study.

F. Guillemin, P. D. de Groot, V. Poindron, 2020, The journal of applied laboratory medicine.

Reversal of the inhibitory effect of fondaparinux on thrombin generation by rFVIIa, aPCC and PCC.

C. Négrier, Y. Dargaud, H. Desmurs-Clavel, 2009, Thrombosis research.

Comparison of the capacities of two prothrombin complex concentrates to restore thrombin generation in plasma from orally anticoagulated patients: an in vitro study

C. Négrier, Y. Dargaud, J. Bordet, 2008, Journal of thrombosis and haemostasis : JTH.

2008 French national guidelines for the treatment of venous thromboembolism in patients with cancer: report from the working group.

D. Farge, H. Lévesque, G. Meyer, 2010, Critical reviews in oncology/hematology.

SOR guidelines for the treatment of venous thromboembolism in patients with cancer : Report from the working group

D. Farge, H. Lévesque, G. Meyer, 2009 .

Standards, Options : Recommandations 2008 Traitement curatif de la maladie thromboembolique veineuse, prévention et traitement des thromboses veineuses sur cathéter chez les patients atteints de cancer

I. Elalamy, H. Desmurs-Clavel, I. Quéré, 2008 .

[2008 Standards, Options: recommendations for venous thromboembolic events (VTE) treatment and central venous catheter thrombosis (CVCT) management in cancer patients].

H. Lévesque, G. Meyer, P. Mismetti, 2008, Bulletin du cancer.

Reversal of rivaroxaban anticoagulant effect by prothrombin complex concentrates: which dose is sufficient to restore normal thrombin generation?

Y. Dargaud, H. Desmurs-Clavel, Y. Jourdy, 2020, Thrombosis Journal.

Determinants of Hydroxychloroquine Blood Concentration Variations in Systemic Lupus Erythematosus

X. Mariette, J. Hulot, Z. Amoura, 2015, Arthritis & rheumatology.

Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)

J. Piette, J. Hulot, Z. Amoura, 2012, Annals of the rheumatic diseases.

Hypofibrinolytic state and high thrombin generation may play a major role in SARS‐COV2 associated thrombosis

L. Argaud, C. Négrier, M. Simon, 2020, Journal of Thrombosis and Haemostasis.

Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides

P. Ravaud, O. Decaux, B. Bonnotte, 2018, Annals of the rheumatic diseases.

Sustained Remission of Granulomatosis With Polyangiitis After Discontinuation of Glucocorticoids and Immunosuppressant Therapy: Data From the French Vasculitis Study Group Registry

E. Thervet, C. Charasse, L. Mouthon, 2021 .

Rituximab versus azathioprine for maintenance in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (MAINRITSAN): Follow-up at 34 months

O. Decaux, L. Mouthon, F. Maurier, 2013 .

Fourteen-day survival among older adults with severe infection with severe acute respiratory syndrome coronavirus 2 treated with corticosteroid: a cohort study

N. Benech, J. Reuter, F. Lescure, 2021, Clinical Microbiology and Infection.

Fourteen-day survival among older adults with severe infection with severe acute respiratory syndrome coronavirus 2 treated with corticosteroid: a cohort study

N. Benech, J. Reuter, F. Lescure, 2021, Clinical Microbiology and Infection.

Reactive Hemophagocytic Syndrome in Adult-Onset Still Disease: Clinical Features and Long-Term Outcome: A Case-Control Study of 8 Patients

M. Ffrench, J. Ninet, A. Hot, 2010, Medicine.

A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study

C. Négrier, P. Gaucherand, Y. Dargaud, 2009, British journal of haematology.

Personalized thromboprophylaxis using a risk score for the management of pregnancies with high risk of thrombosis: a prospective clinical study

P. Gaucherand, Y. Dargaud, J. Ninet, 2017, Journal of thrombosis and haemostasis : JTH.

Soluble CD163 and incident cardiovascular events in patients with systemic lupus erythematosus: An observational cohort study

Z. Amoura, N. Costedoat-Chalumeau, V. Guern, 2022, Journal of internal medicine.

[2008 Standards, Options: Recommendations for venous thromboembolic events(VTE)treatment and central venous catheter thrombosis(CVCT) management in cancer patients].

H. Lévesque, G. Meyer, P. Mismetti, 2008, Journal des maladies vasculaires.

[Standards, Options: recommendations 2008; thromboembolic events treatment, prophylaxis and treatment of central venous catheter thrombosis in patients with cancer].

H. Lévesque, G. Meyer, P. Mismetti, 2008, Annales Francaise d'Anesthesie et de Reanimation.

Increased blood viscosity and red blood cell aggregation in patients with COVID‐19

Y. Bertrand, P. Joly, Y. Dargaud, 2021, American journal of hematology.

Neurological manifestations and neuroradiological presentation of Erdheim-Chester disease: report of 6 cases and systematic review of the literature

J. Piette, D. Vital-Durand, F. Cotton, 2006, Journal of Neurology.

Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study

R. Jaussaud, L. Mouthon, E. Hachulla, 2015, Annals of the rheumatic diseases.

[Recommendations for venous thromboembolic events treatment and central venous catheter thrombosis management in cancer patients].

H. Lévesque, G. Meyer, P. Mismetti, 2009, Presse medicale.

Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. A prospective study in 117 patients

P. Ravaud, O. Decaux, B. Bonnotte, 2013 .

Quality of life in systemic lupus erythematosus: description in a cohort of French patients and association with blood hydroxychloroquine levels

J. Piette, Z. Amoura, N. Costedoat-Chalumeau, 2016, Lupus.

Proposal of the French Society of Vascular Medicine for the prevention, diagnosis and treatment of venous thromboembolic disease in outpatients with COVID-19

G. Mahé, M. Sprynger, G. Boge, 2020, JMV-Journal de Médecine Vasculaire.

Lower vitamin D levels are associated with higher systemic lupus erythematosus activity, but not predictive of disease flare-up

J. Piette, J. Hulot, J. Souberbielle, 2014, Lupus Science & Medicine.